Status:
COMPLETED
Stimulation Test With Intranasal Glucagon for Corticotroph, Somatotroph and Antidiuretic Axes
Lead Sponsor:
A.O.U. Città della Salute e della Scienza
Conditions:
Hypopituitarism
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The diagnosis of secondary hypoadrenalism and GH deficiency (GHD) often requires the performance of a dynamic test. The glucagon stimulation test (GST) is one of the options for evaluating hypothalami...
Eligibility Criteria
Inclusion
- \- Any adult healthy subject (age \>= 18 years old) and not meeting the exclusion criteria listed below
Exclusion
- BMI \< 18.5 kg/m2 or \> 25 kg/m2
- Any active pharmacological treatment
- Pregnancy or breastfeeding
Key Trial Info
Start Date :
October 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05206149
Start Date
October 1 2021
End Date
December 31 2021
Last Update
January 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AOU Città della Salute e della Scienza
Turin, Piedmont, Italy, 10126